Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Therese S Geraci

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Cardiovascular Nursing|December 19, 2003
What ALLHAT tells us about treating high-risk patients with hypertension and hyperlipidemiaTherese S Geraci, Stephen A Geraci
Southern Medical Journal|October 8, 2013
Authors' responseTherese S Geraci, Stephen A Geraci
Southern Medical Journal|July 4, 2013
Considerations in women with hypertensionTherese S Geraci, Stephen A Geraci
Journal of Clinical Hypertension (Greenwich, Conn.)|December 23, 2003
Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Vasilios Papademetriou, Linda B Piller, Charles E Ford, et al.
The American Journal of Cardiology|July 12, 2007
Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialConnie Kingry, Arnaud Bastien, Gillian Booth, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Cardiovascular Nursing|December 19, 2003
What ALLHAT tells us about treating high-risk patients with hypertension and hyperlipidemiaTherese S Geraci, Stephen A Geraci
Southern Medical Journal|October 8, 2013
Authors' responseTherese S Geraci, Stephen A Geraci
Southern Medical Journal|July 4, 2013
Considerations in women with hypertensionTherese S Geraci, Stephen A Geraci
Journal of Clinical Hypertension (Greenwich, Conn.)|December 23, 2003
Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Vasilios Papademetriou, Linda B Piller, Charles E Ford, et al.
The American Journal of Cardiology|July 12, 2007
Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialConnie Kingry, Arnaud Bastien, Gillian Booth, et al.
Pageof 1